Healthcare provider profile · identity verified

Matthew Trowbridge Salisbury, M.D.

Family Practice · CRANSTON, RI · NPI 1477511236

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	601	179
Amlodipine Besylate	Amlodipine Besylate	294	85
Lisinopril	Lisinopril	257	85
Losartan Potassium	Losartan Potassium	256	75
Omeprazole	Omeprazole	234	73
Metformin Hcl	Metformin Hcl	216	60
Levothyroxine Sodium	Levothyroxine Sodium	201	49
Albuterol Sulfate Hfa	Albuterol Sulfate	146	39
Fluticasone Propionate	Fluticasone Propionate	140	48
Furosemide	Furosemide	136	42
Gabapentin	Gabapentin	134	29
Simvastatin	Simvastatin	134	35
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	122	14
Metoprolol Succinate	Metoprolol Succinate	121	39
Sertraline Hcl	Sertraline Hcl	120	39
Pioglitazone Hcl	Pioglitazone Hcl	112	31
Montelukast Sodium	Montelukast Sodium	108	30
Trazodone Hcl	Trazodone Hcl	105	30
Meloxicam	Meloxicam	100	25
Rosuvastatin Calcium	Rosuvastatin Calcium	100	34
Atenolol	Atenolol	92	24
Metoprolol Tartrate	Metoprolol Tartrate	92	29
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	90	19
Hydrochlorothiazide	Hydrochlorothiazide	88	31
Tamsulosin Hcl	Tamsulosin Hcl	84	28
Pantoprazole Sodium	Pantoprazole Sodium	83	30
Pravastatin Sodium	Pravastatin Sodium	75	21
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	67	16
Quetiapine Fumarate	Quetiapine Fumarate	67	14
Allopurinol	Allopurinol	63	20
Citalopram Hbr	Citalopram Hydrobromide	62	18
Jardiance	Empagliflozin	61	11
Ibuprofen	Ibuprofen	59	20
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	59	suppressed
Eliquis	Apixaban	54	12
Raloxifene Hcl	Raloxifene Hcl	52	suppressed
Alprazolam	Alprazolam	51	13
Carvedilol	Carvedilol	51	11
Escitalopram Oxalate	Escitalopram Oxalate	51	15
Celecoxib	Celecoxib	50	13
Tramadol Hcl	Tramadol Hcl	50	suppressed
Metformin Hcl Er	Metformin Hcl	49	19
Prednisone	Prednisone	49	37
Clonazepam	Clonazepam	47	suppressed
Clopidogrel	Clopidogrel Bisulfate	47	13
Glimepiride	Glimepiride	47	16
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	45	11
Famotidine	Famotidine	45	11
Tizanidine Hcl	Tizanidine Hcl	45	12
Ezetimibe	Ezetimibe	44	13
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	44	12
Diclofenac Sodium	Diclofenac Sodium	42	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	40	12
Mirtazapine	Mirtazapine	40	16
Duloxetine Hcl	Duloxetine Hcl	39	11
Propranolol Hcl	Propranolol Hcl	38	13
Ventolin Hfa	Albuterol Sulfate	33	11
Alendronate Sodium	Alendronate Sodium	31	13
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	31	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	31	suppressed
Pregabalin	Pregabalin	30	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	29	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	27	suppressed
Valacyclovir	Valacyclovir Hcl	27	12
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	26	18
Lorazepam	Lorazepam	26	suppressed
Paroxetine Hcl	Paroxetine Hcl	26	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	25	suppressed
Januvia	Sitagliptin Phosphate	25	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Oxycodone Hcl	Oxycodone Hcl	25	suppressed
Ozempic	Semaglutide	25	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	25	suppressed
Baclofen	Baclofen	24	suppressed
Valsartan	Valsartan	24	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	23	20
Farxiga	Dapagliflozin Propanediol	23	suppressed
Felodipine Er	Felodipine	23	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	22	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	21	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	21	suppressed
Meclizine Hcl	Meclizine Hcl	21	12
Qvar Redihaler	Beclomethasone Dipropionate	21	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	21	19
Acetaminophen-Codeine	Acetaminophen With Codeine	20	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	20	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	20	suppressed
Finasteride	Finasteride	19	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	19	suppressed
Irbesartan	Irbesartan	19	suppressed
Sildenafil Citrate	Sildenafil Citrate	19	suppressed
Xarelto	Rivaroxaban	19	suppressed
Bupropion Xl	Bupropion Hcl	18	suppressed
Fenofibrate	Fenofibrate	18	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	18	18
Varenicline Tartrate	Varenicline Tartrate	18	suppressed
Verapamil Er	Verapamil Hcl	18	suppressed
Warfarin Sodium	Warfarin Sodium	18	suppressed
Amoxicillin	Amoxicillin	17	suppressed
Bupropion Hcl Sr	Bupropion Hcl	17	suppressed
Potassium Chloride	Potassium Chloride	17	suppressed
Nystatin	Nystatin	16	suppressed
Symbicort	Budesonide/Formoterol Fumarate	16	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	16	11
Combivent Respimat	Ipratropium/Albuterol Sulfate	15	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	15	suppressed
Ketoconazole	Ketoconazole	15	suppressed
Rizatriptan	Rizatriptan Benzoate	15	suppressed
Synthroid	Levothyroxine Sodium	15	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	15	suppressed
Arnuity Ellipta	Fluticasone Furoate	14	suppressed
Glipizide	Glipizide	14	suppressed
Glipizide Er	Glipizide	14	suppressed
Lithium Carbonate	Lithium Carbonate	14	suppressed
Mounjaro	Tirzepatide	14	suppressed
Buspirone Hcl	Buspirone Hcl	13	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	13	suppressed
Humalog Mix 75-25 Kwikpen	Insulin Lispro Protamin/Lispro	13	suppressed
Methadone Hcl	Methadone Hcl	13	suppressed
Sulfasalazine	Sulfasalazine	13	suppressed
Azelastine Hcl	Azelastine Hcl	12	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Humalog Kwikpen U-100	Insulin Lispro	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Incruse Ellipta	Umeclidinium Bromide	12	suppressed
Klor-Con M20	Potassium Chloride	12	suppressed
Lovastatin	Lovastatin	12	suppressed
Naproxen	Naproxen	12	suppressed
Wellbutrin Xl	Bupropion Hcl	12	suppressed
Azithromycin	Azithromycin	11	suppressed
Calcitriol	Calcitriol	11	suppressed
Hydrocortisone	Hydrocortisone	11	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	11	suppressed
Ropinirole Hcl	Ropinirole Hcl	11	suppressed
Temazepam	Temazepam	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error